Rare damaging variants in IGFALS, which encodes a component of the IGF-1 ternary complex, lowered circulating IGF-1 and were nominally associated with shorter childhood height (indicative of lower IGF-1 bioactivity) and higher risk of T2D. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.